Screener
Hemab Therapeutics Holdings, Inc. COAG Cash Flow Statement
| Q2 '26 | Q1 '26 | Q2 '25 | ||
|---|---|---|---|---|
| -$24.15M-97.8% | -$22.69M-48.2% | -$12.21M— | ||
| $75K-2.6% | $73K-2.7% | $77K— | ||
| -$22.64M-47.6% | -$21.58M-65.6% | -$15.33M— | ||
| $23K— | $112K+600% | —— | ||
| -$107.44M-600% | -$15.85M-164% | $21.5M— | ||
| $317.58M+1,058,697% | -$460K-1,486% | -$30K— | ||
| $187.51M— | -$38.11M-100% | —— | ||
| -$22.66M-47.8% | -$21.7M-66.3% | -$15.33M— |
FAQ
- How much cash does Hemab Therapeutics Holdings, Inc. generate?
- Hemab Therapeutics Holdings, Inc. (COAG) generated -$72.6M in operating cash flow over the trailing twelve months.
- What is Hemab Therapeutics Holdings, Inc.'s free cash flow?
- Hemab Therapeutics Holdings, Inc.'s free cash flow was -$72.7M over the trailing twelve months.
- Where does Hemab Therapeutics Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Hemab Therapeutics Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.